MTERFD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.694400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.237200E-01
Normal-vs-Stage2
7.844000E-01
Normal-vs-Stage3
3.631200E-01
Normal-vs-Stage4
9.699600E-01
Stage1-vs-Stage2
8.975400E-01
Stage1-vs-Stage3
3.109600E-01
Stage1-vs-Stage4
8.344800E-01
Stage2-vs-Stage3
3.134400E-01
Stage2-vs-Stage4
7.045000E-01
Stage3-vs-Stage4
4.490600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.996400E-01
Normal-vs-AfricanAmerican
6.532000E-01
Normal-vs-Asian
6.264600E-01
Caucasian-vs-AfricanAmerican
6.607000E-01
Caucasian-vs-Asian
5.461400E-01
AfricanAmerican-vs-Asian
9.912200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.469200E-01
Normal-vs-Female
9.082600E-01
Male-vs-Female
2.563200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.146800E-01
Normal-vs-Age(41-60Yrs)
9.307600E-01
Normal-vs-Age(61-80Yrs)
6.214200E-01
Normal-vs-Age(81-100Yrs)
9.366000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.039200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.370200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.930600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.874000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.861000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.679600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.733800E-01
Normal-vs-Daily Drinker
7.682000E-01
Normal-vs-Weekly Drinker
9.631400E-01
Normal-vs-Occasional Drinker
5.105000E-01
Normal-vs-Social Drinker
8.893000E-01
Non Drinker-vs-Daily Drinker
9.500600E-01
Non Drinker-vs-Weekly Drinker
5.419800E-01
Non Drinker-vs-Occasional Drinker
9.702800E-01
Non Drinker-vs-Social Drinker
7.018600E-01
Daily Drinker-vs-Weekly Drinker
5.646200E-01
Daily Drinker-vs-Occasional Drinker
9.071200E-01
Daily Drinker-vs-Social Drinker
7.273200E-01
Weekly Drinker-vs-Occasional Drinker
4.759200E-01
Weekly Drinker-vs-Social Drinker
7.826000E-01
Occasional Drinker-vs-Social Drinker
5.474000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.873400E-01
Normal-vs-Grade 2
9.414400E-01
Normal-vs-Grade 3
9.969000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.519400E-01
Grade 1-vs-Grade 3
6.450100E-02
Grade 1-vs-Grade 4
8.873400E-01
Grade 2-vs-Grade 3
1.932440E-01
Grade 2-vs-Grade 4
9.414400E-01
Grade 3-vs-Grade 4
9.969000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.618000E-01
Normal-vs-NonDiabetic
7.731000E-01
Diabetic-vs-NonDiabetic
2.440400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.462600E-01
Normal-vs-NoPancreatitis
7.021200E-01
Pancreatitis-vs-NoPancreatitis
3.861800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.533400E-01
Normal-vs-N1
8.505000E-01
N0-vs-N1
4.942400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.368400E-01
Normal-vs-TP53-NonMutant
4.837400E-01
TP53-Mutant-vs-TP53-NonMutant
7.989100E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
